Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-19 Sale |
2021-08-20 6:05 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
20,000 | $99.49 | $1,989,744 | 1,595,870 (Indirect Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 6:00 pm |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
2,614 | $120.61 | $315,263 | 16,561 (Direct) |
View |
| 2021-07-07 Sale |
2021-07-08 6:00 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $107.87 | $2,696,826 | 1,615,870 (Indirect Direct) |
View |
| 2021-06-30 Sale |
2021-07-02 6:01 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $122 | $3,660,000 | 307,750 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:00 pm |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
12,045 | $106.34 | $1,280,897 | 19,175 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:00 pm |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
78,580 | $107.35 | $8,435,365 | 477,074 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:00 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
45,000 | $107.69 | $4,846,016 | 337,750 (Direct) |
View |
| 2021-04-21 Sale |
2021-04-23 4:45 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $70.49 | $1,762,216 | 1,640,774 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 5:40 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
25,000 | $81.78 | $2,044,485 | 365,250 (Direct) |
View |
| 2020-12-30 Sale |
2021-01-04 5:32 pm |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
43,842 | $83.26 | $3,650,144 | 359,121 (Direct) |
View |
| 2020-12-30 Sale |
2021-01-04 5:31 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
22,300 | $84.94 | $1,894,125 | 1,193,957 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-24 Other |
2021-08-26 3:48 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 |
4,364,999 | $0 | 6,125,373 (Indirect) |
View |
| 2021-08-19 Exercise |
2021-08-20 6:05 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,000 | $1.03 | 1,595,870 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-20 6:05 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,000 | $0 | 1,595,870 (Direct) |
View |
| 2021-08-06 Other(A) |
2021-08-16 5:14 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
3,311,722 | $0 | 4,269,661 (Indirect) |
View |
| 2021-08-06 Other |
2021-08-10 5:24 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 |
2,361,237 | $0 | 2,368,844 (Indirect) |
View |
| 2021-07-06 Exercise |
2021-07-08 6:00 pm |
N/A 2030-02-05 |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
2,614 | $0 | 16,561 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
2,614 | $17 | 16,561 (Direct) |
View |
| 2021-07-07 Exercise |
2021-07-08 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $1.03 | 1,615,870 (Direct) |
View |
| 2021-07-07 Exercise |
2021-07-08 6:00 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $0 | 1,615,870 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 6:01 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $13.68 | 307,750 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 6:01 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $0 | 307,750 (Direct) |
View |
| 2021-06-30 Other |
2021-07-02 5:20 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
202,011 | $0 | 3,335,597 (Indirect) |
View |
| 2021-06-30 Other |
2021-07-02 5:19 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner |
208,052 | $0 | 3,357,682 (Indirect) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A 2030-02-05 |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
12,045 | $0 | 19,175 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
12,045 | $17 | 19,175 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A 2030-02-05 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
78,580 | $0 | 477,074 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
78,580 | $17 | 477,074 (Direct) |
View |
| 2021-06-29 Other |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer |
32 | $0 | 1,244,557 (Direct) |
View |
| 2021-06-25 Acquisition |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer |
64 | $0 | 1,244,557 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
45,000 | $13.68 | 337,750 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
45,000 | $0 | 337,750 (Direct) |
View |
| 2021-06-25 Other |
2021-06-29 5:22 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner |
416,104 | $0 | 3,961,048 (Indirect) |
View |
| 2021-06-25 Other |
2021-06-29 5:20 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
404,022 | $0 | 3,935,597 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Beam Therapeutics Inc. 10% Owner |
2,779,256 | $0 | 546,970 (Direct) |
View |
Ownership |
2021-06-16 9:11 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Beam Therapeutics Inc. 10% Owner |
0 | $0 | 546,970 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 08:02 am |
N/A 2031-06-10 |
Beam Therapeutics Inc. | BEAM | Fishman Mark Director |
6,877 | $0 | 6,877 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 07:57 am |
N/A 2031-06-10 |
Beam Therapeutics Inc. | BEAM | Ho Carole Director |
6,877 | $0 | 6,877 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 07:55 am |
N/A 2031-06-10 |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
6,877 | $0 | 6,877 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 07:53 am |
N/A 2031-06-10 |
Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director |
3,126 | $0 | 3,126 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 07:52 am |
N/A 2031-06-10 |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
6,877 | $0 | 6,877 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-23 4:45 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
6,000 | $1.03 | 1,640,774 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-23 4:45 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
6,000 | $0 | 1,640,774 (Direct) |
View |
| 2021-03-18 Acquisition |
2021-04-12 7:29 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer |
97 | $0 | 1,263,429 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:20 pm |
N/A 2031-03-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
208,125 | $0 | 1,402,082 (Direct) |
View |
| 2021-03-05 Exercise |
2021-04-02 5:13 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
4,030 | $0.67 | 360,175 (Direct) |
View |
| 2021-03-05 Exercise |
2021-04-02 5:13 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
4,030 | $0 | 360,175 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:13 pm |
N/A 2031-03-31 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
75,000 | $0 | 360,175 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:11 pm |
N/A 2031-03-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
52,500 | $0 | 59,809 (Direct) |
View |
| 2021-03-31 Other |
2021-04-02 3:21 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
202,011 | $0 | 3,929,564 (Indirect) |
View |
| 2021-03-31 Other |
2021-04-02 3:20 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | NELSEN ROBERT Director 10% Owner |
204,686 | $0 | 3,940,258 (Indirect) |
View |
| 2021-03-31 Other |
2021-04-02 3:19 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
203,366 | $0 | 3,927,319 (Indirect) |
View |
| 2021-03-18 Other |
2021-03-22 7:39 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | NELSEN ROBERT Director 10% Owner |
409,367 | $0 | 4,540,253 (Indirect) |
View |
| 2021-03-18 Other |
2021-03-22 7:37 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
404,023 | $0 | 4,529,565 (Indirect) |
View |
| 2021-03-18 Other |
2021-03-22 7:34 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
406,731 | $0 | 4,529,873 (Indirect) |
View |
| 2021-01-28 Other |
2021-02-01 2:41 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
356,673 | $0 | 8,041,932 (Indirect) |
View |
| 2021-01-10 Option Award |
2021-01-11 5:26 pm |
N/A 2031-01-09 |
Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director |
11,609 | $0 | 11,609 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-05 5:40 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
25,000 | $13.68 | 365,250 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-05 5:40 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
25,000 | $0 | 365,250 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 5:32 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
43,842 | $1.03 | 359,121 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 5:32 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
12,000 | $0.67 | 359,121 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 5:32 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
55,842 | $0 | 359,121 (Direct) |
View |
| 2020-09-30 Exercise |
2020-10-02 5:49 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
3,731 | $0.67 | 273,175 (Direct) |
View |
| 2020-09-30 Exercise |
2020-10-02 5:49 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
3,731 | $0 | 273,175 (Direct) |
View |